NTHRYS › PhD Assistance › Health Economics
Select a category to explore research frontiers
Loading categories...
Evaluates cost-effectiveness of blood pressure agents, SGLT2 inhibitors, and GLP-1 agonists in slowing chronic kidney disease progression economically.
All Health Economics PhD categories